Biogen's upcoming earnings report is raising questions among investors about its performance.
Biogen Inc (BIIB) is set to report its next earnings, and analysts are curious if the company will exceed expectations again. With a last close of US$216.75, the stock has increased by 24.93% year-to-date, showing a positive trend despite market fluctuations.
Investor takeaway: Keep an eye on the upcoming earnings report for insights into Biogen's financial health and future prospects.
Advertisement
Biogen Inc
BIIB.US
BIIB.US
Biogen Inc
WealthAwesomeMarket cap
$32.82B
P/E
39.5x
52W high
$230.49
52W low
$138.00
1W change
-1.65%
Beta
0.09
Analyst Price Targets
Based on 35 analysts covering BIIB · as of Oct 5, 2026
Wall Street analysts forecast BIIB stock price to rise 7.2% over the next 12 months.
Consensus
Buy4.11 / 5.00
Avg. Target
C$238.18
+7.2% Upside
Current Price
C$222.15
Last close
Analyst Breakdown (35 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on BIIB's historical volatility
30-Day Vol
23.0%
Annualized
90-Day Vol
35.3%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$265.58
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$235.77 | C$217.77 – C$255.27 |
| 60 trading days | C$250.23 | C$223.64 – C$279.99 |
| 90 trading days | C$265.58 | C$231.44 – C$304.76 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Biogen's Last Close at US$216.75 with 325,214 Shares Traded
The latest trading volume was 1.17 times the 20-day average, indicating increased interest ahead of the earnings report.
Bull case
If Biogen surpasses estimates, it could boost investor confidence and support the stock's upward trend.
Bear case
If the company fails to meet earnings expectations, it may lead to a drop in stock price and investor sentiment.
Biogen's Upcoming Earnings Report
Advertisement
Biogen is preparing to release its earnings report, and analysts are eager to see if the company will exceed estimates. The stock closed at US$216.75, down 0.33% for the day. Over the past week, it has declined by 1.65%, but has shown a modest gain of 0.60% over the last month. The year-to-date performance remains strong, with a notable increase of 24.93%. Investors are particularly interested in metrics accompanying the earnings, such as revenue growth and guidance for future quarters.
Stock Performance and Trading Volume Insights
As of the last trading session, Biogen's stock closed at US$216.75, reflecting a slight decrease of 0.33% for the day. The trading volume was recorded at 325,214 shares, which is 1.17 times the 20-day average volume of 1,111,955 shares. The current price is above the 50-day moving average of US$216.18, indicating a positive short-term trend, and it is also significantly higher than the 200-day moving average of US$195.71. The stock is currently trading within a 52-week range of US$138.00 to US$230.49, positioning it at about 85% of its range.
What to Watch Ahead of the Earnings Release
Investors should keep an eye on the earnings per share (EPS) figure, which stands at 5.63 for the trailing twelve months. Additionally, the average analyst target price is US$238.18, presenting an implied upside of 9.9% from the last close. The stock has a P/E ratio of approximately 39.46, reflecting investor expectations for future growth. Any guidance provided during the earnings call will be crucial for understanding Biogen's outlook and potential growth strategies.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
